Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients
Molecular Oncology · 2026-11 · 20 (11) · 2647-2655
DOI: 10.1002/1878-0261.70244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 26.03.2026. Verfasst von Stefan Werner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Extracellular Vesicles, Gene Expression Profiling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Early detection of cancer is essential for effective treatment. However, current prostate cancer screening methods lack sufficient sensitivity and specificity, leading to overdiagnosis and unnecessary treatment. There is also an unmet need to distinguish clinically significant from insignificant prostate cancer. To identify complementary biomarkers for improved screening and diagnosis, we performed transcriptional profiling of cancer‐associated transcripts in circulating extracellular vesicles (EVs) isolated from peripheral blood of patients with suspected prostate cancer prior to biopsy and healthy donors. Expression data for 2549 mRNAs were obtained from 28 men. CAPN5 expression was significantly lower, whereas BIRC2, CASP3, CD63, FMO5, IRF6, PFDN1, PRDX6, PSMD2, RIT1, S100A2, THBS1 , and XRCC2 were significantly elevated in EVs from patients with significant prostate cancer ( n = 14) compared with cancer‐free individuals and patients with insignificant disease ( n = 14). Candidate biomarkers were subsequently evaluated by in silico validation using the The Cancer Genome Atlas (TCGA) prostate adenocarcinoma dataset and the GEO dataset GSE70768 containing benign and malignant prostate tissues. This analysis identified CASP3 , XRCC2 , and RIT1 transcripts in circulating EVs as promising biomarkers for the early detection of significant prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany.
- The PROLIPSY consortium, Hamburg, Germany.
- Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Germany.
- Bioinformatics Core, University Medical Center Hamburg-Eppendorf, Germany.
- Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.
- Department of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Germany.
ORCID-Profile: Stefan Werner, Joanna Budna-Tukan, Evi Lianidou, Catherine Alix-Panabières, Klaus Pantel
Förderung
- European Commission
Zitieren
APA
Werner, S., Tennstedt, P., Pose, R. C., Müller, C., Besler, K., Schneegans, S., Alawi, M., Roesch, M. C., Peine, S., Bonci, D., Budna-Tukan, J., Lianidou, E., Alix-Panabières, C., Tilki, D., & Pantel, K. (2026). Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients. Molecular Oncology, 20(11), 2647-2655. https://doi.org/10.1002/1878-0261.70244
Vancouver
Werner S, Tennstedt P, Pose RC, Müller C, Besler K, Schneegans S, et al. Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients. Molecular Oncology. 2026;20(11):2647-2655. doi:10.1002/1878-0261.70244
BibTeX
@article{Werner2026,
author = {Werner, Stefan and Tennstedt, Pierre and Pose, Randi C and Müller, Christian and Besler, Katharina and Schneegans, Svenja and Alawi, Malik and Roesch, Marie C and Peine, Sven and Bonci, Desiree and Budna-Tukan, Joanna and Lianidou, Evi and Alix-Panabières, Catherine and Tilki, Derya and Pantel, Klaus},
title = {Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients},
journal = {Molecular Oncology},
year = {2026},
volume = {20},
number = {11},
pages = {2647--2655},
doi = {10.1002/1878-0261.70244}
}
EUVIMED